April Parliamentary Session Begins with Uncertain Outcome for Pharmaceutical Reform Bill

The domestic pharmaceutical industry is giving its close attention to the National Assembly spring session, which has officially started from April 6th, on the proposed Korea Pharmaceutical Affairs Law (KPAL) reform bill including the corporate pharmacy system.

Continuing from the last round of parliamentary session, the ruling and the opposition parties are expected to be largely in debate ...